- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (710)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (4)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (620)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (880)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1762)
Energy Transfer and Sunoco donate more than $2 million to support research at MD Anderson
2 minute read | Published December 07, 2023
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on December 07, 2023
Employee giving campaign has raised more than $15 million over ten years
HOUSTON ― Leaders from The University of Texas MD Anderson Cancer Center were presented with more than $2 million from Energy Transfer and Sunoco. The funds, which will support pediatric cancer research at MD Anderson Children’s Cancer Hospital, were raised through the companies’ annual workplace giving campaign.
“We are grateful, year after year, for the unmatched generosity of Energy Transfer and Sunoco,” said Richard Gorlick, M.D., division head and chair of Pediatrics at MD Anderson. “Because of their commitment to our mission to end cancer, patients now and in the future will have access to better, more effective treatments through a new and improved standard of care.”
Since 2014, Energy Transfer and Sunoco employees have led a fundraising effort that has donated more than $15 million to MD Anderson. The annual campaign includes contributions from corporate funds and $1 million from the Energy Transfer/Sunoco Foundation. CAL's Convenience, an independent agent operator of more than 200 Stripes stores at Sunoco gas stations, contributed $65,000 to the effort this year. Every dollar raised will go directly toward MD Anderson’s innovative and lifesaving cancer research and patient programs.
“We are always inspired by the incredible researchers, doctors and nurses within the MD Anderson family,” said Chris Curia, Energy Transfer executive vice president and chief human resources officer. “Their mission, research and treatment efforts are renowned and have had major impacts on millions of patients and their families around the world. It is truly an honor for us to raise money every year to help them further their mission.”
Over the years, funds from Energy Transfer have gone to support numerous research projects, including menin inhibitor research, which is particularly impactful for pediatric patients facing leukemia and other blood diseases.
“Through our research with the menin inhibitor, we are identifying combinations to enhance efficacy and potentially cure more children,” said Branko Cuglievan, M.D., assistant professor of Pediatrics Patient Care at MD Anderson. “With support from Energy Transfer, we are bringing hope to our patients and their families.”

With support from Energy Transfer, we are bringing hope to our patients and their families.
Branko Cuglievan, M.D.
Assistant Professor, Pediatrics Patient Care